A Study on the Effects in Healthy People of a New Drug Called PDI204 for Treating COVID-19
Clinical trial NCT06965751 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06965751
- Sponsor
- University of Melbourne
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-27
- Primary completion
- 2026-07-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.